Expert Opinion on Pharmacotherapy

OCT 14, 2026 · JOURNAL ARTICLE

Contemporary systemic therapy of medullary thyroid cancer

Expert Opinion on Pharmacotherapy

Introduction Medullary thyroid cancer (MTC) is a less common subtype of thyroid cancer, and it should be managed under the care of expert multidisciplinary teams.Areas covered Base

OCT 14, 2026 · JOURNAL ARTICLE

Pharmacotherapy for MASLD/MASH: approved therapies, drug repurposing, and emerging mechanism-based candidates

Expert Opinion on Pharmacotherapy

INTRODUCTION: Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis (MASLD/MASH) pharmacotherapy is changing rapidly after t

OCT 13, 2026 · JOURNAL ARTICLE

Combination therapies for the treatment of locally advanced and advanced cervical cancer

Expert Opinion on Pharmacotherapy

Introduction Cervical cancer remains a significant global health challenge. This narrative review synthesizes evidence from PubMed/MEDLINE, Embase, and ClinicalTrials.gov (January